---
figid: PMC5866782__nihms945682f3
figlink: /pmc/articles/PMC5866782/figure/F3/
number: Figure 3
caption: Mesenchymal stem cells (MSC) localized to the tumor microenvironment produce
  16:4(n-3) PUFA in response to platinum-based chemotherapeutics such as cisplatin
  via an intracellular signaling mechanism that is dependent on Ca+2, PLA2, thromboxane
  synthase (TXAS), and cyclooxygenase-1 (COX1) (). 16:4(n-3) that is released by MSC
  agonizes FFA4 on splenic macrophages (F4/80+/CD11blow in mice, presumably CD163+
  in humans) to activate cytosolic PLA2 via an unresolved pathway that is likely Gαq/11/Ca+2-mediated.
  FFA4-induced activation of cPLA2 forms the lysophosphatidylcholine LPC(24:1), which
  directly alters the ability of platinum-based chemotherapeutics to mediate DNA damage
  responses in cancer cells, leading to chemoresistance to the agents (–).
pmcid: PMC5866782
papertitle: The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer
  cell lines.
reftext: Ilya S. Senatorov, et al. Biochem Pharmacol. ;150:170-180.
pmc_ranked_result_index: '9299'
pathway_score: 0.9532977
filename: nihms945682f3.jpg
figtitle: Free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines
year: ''
organisms: Homo sapiens
ndex: 60c9331f-deef-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5866782__nihms945682f3.html
  '@type': Dataset
  description: Mesenchymal stem cells (MSC) localized to the tumor microenvironment
    produce 16:4(n-3) PUFA in response to platinum-based chemotherapeutics such as
    cisplatin via an intracellular signaling mechanism that is dependent on Ca+2,
    PLA2, thromboxane synthase (TXAS), and cyclooxygenase-1 (COX1) (). 16:4(n-3) that
    is released by MSC agonizes FFA4 on splenic macrophages (F4/80+/CD11blow in mice,
    presumably CD163+ in humans) to activate cytosolic PLA2 via an unresolved pathway
    that is likely Gαq/11/Ca+2-mediated. FFA4-induced activation of cPLA2 forms the
    lysophosphatidylcholine LPC(24:1), which directly alters the ability of platinum-based
    chemotherapeutics to mediate DNA damage responses in cancer cells, leading to
    chemoresistance to the agents (–).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLA2G4D
  - PLA2G2E
  - PLA2G4A
  - PLA2G2C
  - PCSK7
  - MSC
  - PLA2G2F
  - PLA2G7
  - PLA2G3
  - PLA2G1B
  - PLA2G12B
  - PLA2G4C
  - KAT5
  - PLA2G10
  - PLA2G6
  - PLA2G2D
  - TBXAS1
  - PLA2G5
  - PLA2G12A
  - PLA2G2A
  - Cisplatin
  - LPC
  - Cancer
genes:
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: LPC
  symbol: LPC
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK7
  entrez: '9159'
- word: MSC
  symbol: MSC
  source: hgnc_symbol
  hgnc_symbol: MSC
  entrez: '9242'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: CPLA2
  symbol: cPLA2
  source: hgnc_alias_symbol
  hgnc_symbol: KAT5
  entrez: '10524'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2/TXAS/COXı
  symbol: TXAS
  source: hgnc_alias_symbol
  hgnc_symbol: TBXAS1
  entrez: '6916'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PLA2/TXAS/COXı
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: LPC
  source: MESH
  identifier: C470482
diseases:
- word: Cancer
  source: MESH
  identifier: D009369
---
